Comparing honey dressing to Alvogyl for treating dry socket
Exploring the Efficacy of Pure Honey Dressing in Contrast to Alvogyl in the Resolution of Dry Socket: A Comparative Analysis
This study is testing whether honey dressing works better than Alvogyl for helping people with dry socket feel less pain after tooth extraction.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Watim Medical & Dental College Academic / other |
| Locations | 1 site (Multan Khurd, Punjab Province) |
| Trial ID | NCT06456060 on ClinicalTrials.gov |
What this trial studies
This interventional study aims to evaluate the effectiveness of pure honey dressing compared to Alvogyl in treating dry socket, a common complication following tooth extraction. Patients diagnosed with dry socket will be divided into two groups: one receiving honey-soaked gauze and the other receiving Alvogyl. Pain relief will be assessed using a visual analog scale at multiple time points post-treatment. The study will document demographic data and associated medical conditions to ensure a comprehensive analysis of outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 who have undergone tooth extraction and are diagnosed with dry socket.
Not a fit: Patients with systemic diseases, allergies to honey or Ibuprofen, or those under 18 or over 70 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a safer, cost-effective alternative to Alvogyl for treating dry socket.
How similar studies have performed: While Alvogyl is widely used, the use of honey as a dressing is a novel approach that has not been extensively tested in clinical settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients over 18 years of age of both genders. 2. Patients who underwent extraction of teeth and were clinically diagnosed with dry socket at the OMFS department of NID, Multan. 3. Patients which give informed consent. Exclusion Criteria: 1. Patients below the age of 18 and above the age of 70. 2. Patients with various bone diseases, including osteoporosis \& a history of taking oral or intravenous bisphosphonates 3. Patients with a history of radiotherapy on the head, neck, and jawbones were excluded from this study, 4. Patients with systemic diseases such as diabetes mellitus, hepatic dysfunctions, blood dyscrasias, and bleeding disorders 5. Patients with allergy to Ibuprofen \& honey 6. Patients having symptoms similar to dry socket due to retained root pieces, oroantral communication, or any bony or soft tissue pathology by the help of a radiograph 7. Patients who did not give informed consent.
Where this trial is running
Multan Khurd, Punjab Province
- Nishtar Institute of Dentistry — Multan Khurd, Punjab Province, Pakistan (Recruiting)
Study contacts
- Study coordinator: Muhammad Raif Ilyas, BDS, FCPS -1
- Email: raifilyas@gmail.com
- Phone: 00923319268801
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.